Meyka Pro banner
The Pennant Group, Inc.

The Pennant Group, Inc. (PNTG) Stock Overview

Explore The Pennant Group, Inc.’s financial performance, market position, analyst ratings, and future outlook.

PNTGNASDAQ
HealthcareMedical - Care Facilities
$41.08
$0.94(2.24%)
U.S. Market opens in 10h 10m

The Pennant Group, Inc. (PNTG)

Meyka AI Score

Z

Key Financials

Market Cap1.4B
P/E Ratio46.75
EPS (TTM)$1.23
ROE0.09%
Fundamental Analysis

AI Price Forecasts

1 Month$43.66
3 Months$41.16
1 Year Target$36.53

PNTG Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of The Pennant Group, Inc. (NASDAQ: PNTG) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, The Pennant Group, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of PNTG on the NASDAQ shows an RSI of 61.91, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $36.53 for the NASDAQ listing.

Key metrics behind The Pennant Group, Inc.'s NASDAQ-traded stock include a P/E ratio of 46.75 and a market capitalization of 1.4B. Combined with our AI analysis, these give both institutional and retail investors a clear view of PNTG on the NASDAQ.

Price Performance (NASDAQ: PNTG)

1-Day Change
-2.24%
5-Day Change
3.009%
1-Month Change
13.04%
3-Month Change
33.77%
6-Month Change
50.26%
Year-to-Date (YTD) Change
45.93%
1-Year Change
78.76%
3-Year Change
257.84%
5-Year Change
20.05%
All-Time (Max) Change
172.23%

Contact Information

208 506 6100
1675 East Riverside Drive, Eagle, ID, 83616

Company Facts

97,000 Employees
IPO DateOct 1, 2019
CountryUS
Actively Trading

Frequently Asked Questions